Outlook on the Pharmaceuticals Contract Development & Manufacturing Global Market to 2026 - Impact of COVID-19 with Ansoff Analysis
May 19, 2021 04:23 ET
|
Research and Markets
Dublin, May 19, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceuticals Contract Development & Manufacturing Market (2021-2026) by Service, End-user, Geography and the Impact of COVID-19 with...
Recro Reports First Quarter 2021 Financial Results
May 06, 2021 16:05 ET
|
Recro Pharma, Inc.
Revenues of $16.8 Million Represent an Increase of 70% Compared to Q4 2020 Revenue Multiple New Business Agreements Signed Facilities Expansion and Enhancements Continue Company to Host Conference...
Recro to Report Financial Results for Fourth Quarter And Year-End 2020 on February 26
February 19, 2021 16:05 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Recro Strengthens Leadership Team With Key Executive and Board Appointments
February 11, 2021 07:00 ET
|
Recro Pharma, Inc.
Company Names CDMO Industry Thought Leader, Jim Miller, to Board of Directors and Selects Ryan D. Lake as Dedicated Chief Financial OfficerRecent Appointments, including CEO David Enloe, Provide...
Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
January 11, 2021 08:00 ET
|
LEUKOCARE AG
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Germany-based formulation development specialist Leukocare opens US presence to support local...
Starton Therapeutics Selects Formulation for Continuous Subcutaneous Lenalidomide Delivery System for CLL Treatment
January 11, 2021 07:40 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company powering continuous delivery of approved drugs in...
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy
May 21, 2020 06:30 ET
|
Shah Capital
RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead...
Nexeo Solutions Launches New Sampling Site Focused on Personal Care Innovation
December 13, 2018 06:00 ET
|
Nexeo Solutions, Inc.
THE WOODLANDS, Texas, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Nexeo Solutions, Inc. (NASDAQ:NXEO), a leader in chemicals and plastics distribution, announced the launch of its formulations services...
Acne Medication Market revenue worth over $7 billion by 2024: Global Market Insights, Inc.
November 29, 2018 07:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Brazil dominated the Latin America acne medication market and was valued at over USD 110.9 million in the year 2017. Growing prevalence...
Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products
October 03, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) has entered into a research agreement with VivaCell...